Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study highlights environmental risks of isoxazoline
Isoxazoline gained popularity as an oral treatment for fleas and ticks.
Active ingredients from flea treatment pass into pet faeces.

A study has demonstrated how a relatively new class of antiparasitic medication could be endangering the natural environment.

The flea and tick treatment isoxazoline, introduced in 2013, gained popularity as one of the first oral treatments to control flea and ticks for a month or longer.

Pets that take this medication will pass the active compounds through their body, excreting them in their faeces. These substances contaminate ecosystems, particularly killing insects exposed to the faeces.

The drugs are particularly harming dung-feeding insects including flies, dung beetles and some butterflies. These insects have a key role in the environmental ecosystem – breaking down waste, recycling nutrients, improving soil quality and helping control pests.

Researchers in France monitored 20 dogs and 20 cats, owned by veterinary students, as they received isoxazoline treatments over three months.

Samples measured how much of the active ingredients remained in the faeces. Based on this, they estimated how much exposure the dung-feeding insects would face.

The analysis revealed that, even after the treatment period, two of the four active ingredients (fluralaner and lotilaner) in isoxazoline remained in the animals’ faeces.

A following environmental risk assessment suggested that dung-feeding insects could be experiencing high levels of exposure to isoxazoline as a result or routine treatments. Researchers warn this would disrupt important ecological processes and have serious consequences for environmental lifecycles.

The research team says that this discovery should prompt further study into anti-parasitic treatment and its harm to the environment. It has also called for the prolonged faecal elimination of these substances to be mentioned in the medication SPC.

The full study can be found in the journal Environmental Toxicology and Chemistry.

Image © Shutterstock.com/ Ekaterina43

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.